OFFICE OF FISCAL ANALYSIS
Legislative Office Building, Room 5200
Hartford, CT 06106 ↓ (860) 240-0200
AN ACT CONCERNING FAIRNESS IN PHARMACY AND PHARMACY BENEFITS MANAGER CONTRACTS.
As Amended by Senate "A" (LCO 7774), House "A" (LCO 8614)
House Calendar No.: 591
Senate Calendar No.: 295
OFA Fiscal Note
FY 18 $
FY 19 $
GF - Potential Revenue Gain
Note: GF=General Fund
Municipal Impact: None
The bill does not result in a cost to the University of Connecticut Health center as the bill specifies that a hospital is not required to pay for installing, constructing, or building any new information technology, including interfaces, in order to comply with bidirectional connectivity requirements of the bill.
In addition, the bill is not anticipated to result in a fiscal impact to the state or municipalities to comply with the disclosure prohibitions contained in the bill or cost-sharing parameters in section 1(b). Individuals are charged in accordance with cost-sharing requirements of the state health plan or their respective municipal health plans, which are not anticipated to be impacted by the bill.
Lastly, the bill may result in a revenue gain to the General Fund to the extent additional fines or penalties are assessed for violations of the Connecticut Unfair Trade Practices Act.
Senate “A” struck the underlying bill and its associated fiscal impact and results in the impact described above. House “A” made technical and procedural changes which did not result in a fiscal impact.
The Out Years
The potential revenue gain to the General Fund will continue into the future to the extent additional fines or penalties are assessed.
The preceding Fiscal Impact statement is prepared for the benefit of the members of the General Assembly, solely for the purposes of information, summarization and explanation and does not represent the intent of the General Assembly or either chamber thereof for any purpose. In general, fiscal impacts are based upon a variety of informational sources, including the analyst's professional knowledge. Whenever applicable, agency data is consulted as part of the analysis, however final products do not necessarily reflect an assessment from any specific department.